Barbro Kahl Knutson (Former)
1 – 10 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Galectin-8 binds HIV envelope glycoproteins with high affinity and promotes viral infectivity
- Contribution to journal › Article
-
Mark
An Orally Available Halothiazole Glycomimetic as a Cancer-Targeting Dual Galectin-1 and Galectin-3 Inhibitor
- Contribution to journal › Article
- 2025
-
Mark
Design, synthesis, and evaluation of a novel fluorescent probe for competitive fluorescence polarization assay to screen galectin-8 inhibitors
- Contribution to journal › Article
- 2024
-
Mark
Discovery of the Selective and Orally Available Galectin-1 Inhibitor GB1908 as a Potential Treatment for Lung Cancer
- Contribution to journal › Article
-
Mark
Determining the Affinity and Kinetics of Small Molecule Inhibitors of Galectin-1 Using Surface Plasmon Resonance
- Contribution to journal › Article
-
Mark
The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis
- Contribution to journal › Article
-
Mark
Development and Characterization of a High-Affinity Selective Galectin-3 Mouse Tool Compound in Mouse Models of Cancer
- Contribution to journal › Article
- 2023
-
Mark
Evaluating the affinity and kinetics of small molecule glycomimetics for human and mouse galectin-3 using surface plasmon resonance
- Contribution to journal › Article
-
Mark
Discovery of Selective and Orally Available Galectin-1 Inhibitors
- Contribution to journal › Article
- 2022
-
Mark
Installation of O-glycan sulfation capacities in human HEK293 cells for display of sulfated mucins
- Contribution to journal › Article
